Researchers at North Carolina State University have developed a nanodecoy system that provides binding sites for the SARS-CoV-2 virus. The vesicles help to prevent the virus from binding to lung cells and lead to its eventual destruction by the immune system. The nanodecoys are derived from lung spheroid cells, and contain the angiotensin-conv (Read more...)